Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: DNA vaccines - Greffex

Drug Profile

Research programme: DNA vaccines - Greffex

Alternative Names: Avian influenza vaccine - Greffex; Aznthrax vaccine - Greffex; Dengue vaccine - Greffex; Ebola virus vaccine - Greffex; GREANX; GREDEN/V1-4; GREFLU/CAL; GREFLU/VIE; GreVac™ vaccines; GREVAX; H1N1 vaccine - Greffex; H7N9 vaccine - Greffex; HIV vaccine - Greffex; MERS-CoV vaccine - Greffex; Middle east respiratory syndrom coronavirus vaccine - Greffex; Plague vaccine - Greffex; Tuberculosis vaccine - Greffex; Universal influenza vaccine - Greffex

Latest Information Update: 28 Sep 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Greffex Inc
  • Class Anthrax vaccines; Bacterial vaccines; Dengue vaccines; DNA vaccines; Influenza A virus H1N1 vaccines; Influenza A virus H5N1 vaccines; Influenza virus vaccines; Lyme disease vaccines; Plague vaccines; Tuberculosis vaccines; Viral vaccines; Zika virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Lyme disease; Middle East respiratory syndrome coronavirus; Zika virus infection
  • No development reported Anthrax; Coronavirus infections; Dengue; Ebola virus infections; HIV infections; Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype; Influenza A virus H7N9 subtype; Influenza virus infections; Plague; Tuberculosis

Most Recent Events

  • 28 Sep 2023 No recent reports of development identified for preclinical development in Coronavirus-infections in USA (Parenteral)
  • 28 Aug 2023 No recent reports of development identified for preclinical development in Anthrax in USA (Parenteral)
  • 28 Aug 2023 No recent reports of development identified for preclinical development in Dengue in USA (Parenteral)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top